ES2032384T3 - Procedimiento para preparar derivados de carboxamidas. - Google Patents
Procedimiento para preparar derivados de carboxamidas.Info
- Publication number
- ES2032384T3 ES2032384T3 ES198686308054T ES86308054T ES2032384T3 ES 2032384 T3 ES2032384 T3 ES 2032384T3 ES 198686308054 T ES198686308054 T ES 198686308054T ES 86308054 T ES86308054 T ES 86308054T ES 2032384 T3 ES2032384 T3 ES 2032384T3
- Authority
- ES
- Spain
- Prior art keywords
- formula
- procedure
- compounds
- manufacture
- carboxamide derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D249/18—Benzotriazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
ESTA INVENCION SE REFIERE A SERIES DE NUEVAS AMIDAS HETEROCICLICAS DE FORMULA I EN LAS QUE EL GRUPO X-Y-Z< SE SELECCIONA DE ENTRE >C-CH-N<, >C-N-N<, N-(CH2)- N<, >CH-CH2-N< Y >N-N-C< Y LOS OTROS RADICALES TIENEN LOS SIGNIFICADOS DEFINIDOS EN LA SIGUIENTE ESPECIFICACION LOS COMPUESTOS DE LA FORMULA I SON ANTAGONISTAS DEL LEUCOTRIENO. LA INVENCION TAMBIEN SE REFIERE A LAS SALES ACEPTABLES FARMACEUTICAMENTE DE LOS COMPUESTOS DE LA FORMULA I; COMPOSICIONES FARMACEUTICAS QUE CONTIENEN EL COMPUESTO DE FORMULA I, O SUS SALES, PARA USO EN EL TRATAMIENTO DE, POR EJEMPLO, AFECCIONES INFLAMATORIAS O ALERGICAS O CONDICIONES ENDOTOXICAS O SHOCK TRAUMATICO; Y PROCEDIMIENTOS PARA LA FABRICACION DE PRODUCTOS COMPUESTOS DE LA FORMULA I, ASI COMO DOS INTERMEDIOS PARA SU USO EN LA FABRICACION.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858525658A GB8525658D0 (en) | 1985-10-17 | 1985-10-17 | Heterocyclic amide derivatives |
GB868609176A GB8609176D0 (en) | 1986-04-15 | 1986-04-15 | Carboxamide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2032384T3 true ES2032384T3 (es) | 1993-02-16 |
Family
ID=26289900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES198686308054T Expired - Lifetime ES2032384T3 (es) | 1985-10-17 | 1986-10-16 | Procedimiento para preparar derivados de carboxamidas. |
Country Status (19)
Country | Link |
---|---|
US (3) | US4918094A (es) |
EP (1) | EP0220066B1 (es) |
JP (1) | JP2512724B2 (es) |
KR (1) | KR900004385B1 (es) |
AU (1) | AU595839B2 (es) |
CA (1) | CA1336192C (es) |
DE (1) | DE3684549D1 (es) |
DK (1) | DK169964B1 (es) |
ES (1) | ES2032384T3 (es) |
FI (1) | FI83866C (es) |
GB (1) | GB8623429D0 (es) |
GR (1) | GR3004137T3 (es) |
HK (1) | HK18197A (es) |
HU (1) | HU197724B (es) |
IE (1) | IE60480B1 (es) |
IL (1) | IL80335A (es) |
NO (1) | NO170482C (es) |
NZ (1) | NZ217962A (es) |
PT (1) | PT83558B (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE862737L (en) * | 1985-10-17 | 1987-04-17 | Staehler Theo | Heterocyclic compounds |
US5041460A (en) * | 1988-04-14 | 1991-08-20 | Ici Americas Inc. | Heter-aliphatic carboxamides |
US5286740A (en) * | 1989-12-11 | 1994-02-15 | Imperial Chemical Industries Plc | Carbamoyl derivatives |
GB8927981D0 (en) * | 1989-12-11 | 1990-02-14 | Ici Plc | Carbamoyl derivative |
ES2063479T3 (es) * | 1990-05-04 | 1995-01-01 | Ciba Geigy Ag | Indoles substituidos. |
US5095031A (en) * | 1990-08-20 | 1992-03-10 | Abbott Laboratories | Indole derivatives which inhibit leukotriene biosynthesis |
GB9026427D0 (en) * | 1990-12-05 | 1991-01-23 | Ici Plc | Chemical process |
DE69212058T2 (de) * | 1991-03-11 | 1997-01-09 | Kyowa Hakko Kogyo Kk | Indol-Derivate |
GB9119001D0 (en) * | 1991-09-05 | 1991-10-23 | Ici Plc | Pharmaceutical agents |
EP0539329A1 (de) * | 1991-10-25 | 1993-04-28 | Ciba-Geigy Ag | Acetylen-Verbindungen, verwendbar als Leukotrien-Antagonisten |
EP0539330B1 (de) * | 1991-10-25 | 1995-05-17 | Ciba-Geigy Ag | Verfahren zur Herstellung substituierter Indole |
ES2050611B1 (es) * | 1992-10-08 | 1994-12-16 | Ici Plc | Una nueva forma fisica de un derivado de carbamoilindol con propiedades antagonistas de leucotrienos. |
US5288743A (en) * | 1992-11-20 | 1994-02-22 | Abbott Laboratories | Indole carboxylate derivatives which inhibit leukotriene biosynthesis |
AU6315300A (en) * | 1999-07-26 | 2001-02-13 | Shionogi & Co., Ltd. | Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same |
US6614627B1 (en) * | 2000-02-14 | 2003-09-02 | Hitachi, Ltd. | Magnetic disk apparatus |
JP2012521429A (ja) * | 2009-03-23 | 2012-09-13 | メルク・シャープ・エンド・ドーム・コーポレイション | 疼痛治療用のp2x3受容体アンタゴニスト |
JP2020111510A (ja) * | 2017-03-29 | 2020-07-27 | 科研製薬株式会社 | インダゾール誘導体及びそれを含有する医薬 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3271416A (en) * | 1961-10-24 | 1966-09-06 | Merck & Co Inc | Indolyl aliphatic acids |
FR4035M (es) * | 1964-11-04 | 1966-03-28 | ||
FR7631M (es) * | 1968-08-13 | 1970-01-26 | ||
US3470298A (en) * | 1969-01-29 | 1969-09-30 | Acraf | Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids |
BE738727A (en) * | 1969-09-11 | 1970-02-16 | Anti inflammatory analgesic and antipyretic indolyalkanoic - acids and derivs | |
DE2854987A1 (de) * | 1978-12-20 | 1980-06-26 | Boehringer Mannheim Gmbh | Diagnostische mittel zum nachweis proteolytischer enzyme und dafuer geeignete chromogene |
IE54269B1 (en) * | 1981-12-30 | 1989-08-02 | Ici America Inc | Pharmaceutically active phenylcarboxylic acid derivatives |
CA1241660A (en) * | 1984-06-25 | 1988-09-06 | Yvan Guindon | Indole-2-alkanoic acids |
GB8524157D0 (en) * | 1984-10-19 | 1985-11-06 | Ici America Inc | Heterocyclic amides |
GB8426474D0 (en) * | 1984-10-19 | 1984-11-28 | Ici America Inc | Heterocyclic amides |
GB8607294D0 (en) * | 1985-04-17 | 1986-04-30 | Ici America Inc | Heterocyclic amide derivatives |
-
1986
- 1986-09-30 GB GB868623429A patent/GB8623429D0/en active Pending
- 1986-10-16 AU AU63985/86A patent/AU595839B2/en not_active Ceased
- 1986-10-16 IE IE273886A patent/IE60480B1/en not_active IP Right Cessation
- 1986-10-16 KR KR1019860008670A patent/KR900004385B1/ko not_active IP Right Cessation
- 1986-10-16 DE DE8686308054T patent/DE3684549D1/de not_active Expired - Lifetime
- 1986-10-16 NZ NZ217962A patent/NZ217962A/xx unknown
- 1986-10-16 FI FI864191A patent/FI83866C/fi not_active IP Right Cessation
- 1986-10-16 IL IL80335A patent/IL80335A/xx not_active IP Right Cessation
- 1986-10-16 PT PT83558A patent/PT83558B/pt not_active IP Right Cessation
- 1986-10-16 JP JP61246448A patent/JP2512724B2/ja not_active Expired - Lifetime
- 1986-10-16 US US06/919,845 patent/US4918094A/en not_active Expired - Lifetime
- 1986-10-16 NO NO864130A patent/NO170482C/no not_active IP Right Cessation
- 1986-10-16 HU HU864302A patent/HU197724B/hu not_active IP Right Cessation
- 1986-10-16 DK DK495886A patent/DK169964B1/da not_active IP Right Cessation
- 1986-10-16 ES ES198686308054T patent/ES2032384T3/es not_active Expired - Lifetime
- 1986-10-16 EP EP86308054A patent/EP0220066B1/en not_active Expired - Lifetime
- 1986-10-17 CA CA000520794A patent/CA1336192C/en not_active Expired - Fee Related
-
1989
- 1989-12-29 US US07/458,868 patent/US5049679A/en not_active Expired - Lifetime
- 1989-12-29 US US07/458,876 patent/US5049576A/en not_active Expired - Lifetime
-
1992
- 1992-03-26 GR GR910401149T patent/GR3004137T3/el unknown
-
1997
- 1997-02-13 HK HK18197A patent/HK18197A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GR3004137T3 (es) | 1993-03-31 |
PT83558B (pt) | 1989-05-31 |
JP2512724B2 (ja) | 1996-07-03 |
DK169964B1 (da) | 1995-04-18 |
PT83558A (en) | 1986-11-01 |
CA1336192C (en) | 1995-07-04 |
HK18197A (en) | 1997-02-13 |
HU197724B (en) | 1989-05-29 |
FI864191A (fi) | 1987-04-18 |
US5049679A (en) | 1991-09-17 |
FI83866C (fi) | 1991-09-10 |
GB8623429D0 (en) | 1986-11-05 |
KR900004385B1 (ko) | 1990-06-23 |
NO864130L (no) | 1987-04-21 |
NO170482B (no) | 1992-07-13 |
NO170482C (no) | 1992-10-21 |
EP0220066A3 (en) | 1988-10-12 |
EP0220066A2 (en) | 1987-04-29 |
IE60480B1 (en) | 1994-07-13 |
NO864130D0 (no) | 1986-10-16 |
EP0220066B1 (en) | 1992-03-25 |
IE862738L (en) | 1987-04-17 |
IL80335A (en) | 1990-02-09 |
US4918094A (en) | 1990-04-17 |
KR870003983A (ko) | 1987-05-06 |
NZ217962A (en) | 1990-03-27 |
DK495886A (da) | 1987-04-18 |
JPS6299359A (ja) | 1987-05-08 |
FI83866B (fi) | 1991-05-31 |
HUT42441A (en) | 1987-07-28 |
FI864191A0 (fi) | 1986-10-16 |
AU6398586A (en) | 1987-04-30 |
DE3684549D1 (de) | 1992-04-30 |
AU595839B2 (en) | 1990-04-12 |
DK495886D0 (da) | 1986-10-16 |
US5049576A (en) | 1991-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2032384T3 (es) | Procedimiento para preparar derivados de carboxamidas. | |
AR016762A1 (es) | Compuestos del acido 4-bromo o 4-yodo fenilamino benzohidroxamico, formulaciones farmaceuticas y uso del mismo | |
AR009357A1 (es) | Compuesto de amidas de acido fosfinico y sus usos para preparar una composicion farmaceutica y en un metodo para prevenir o tratar unaenfermedad asociada a la actividad de metaloproteasa | |
NO159378C (no) | Analogifremgangsmaate for fremstilling an nye n-(3-hydroksy-4-piperidinyl)benzamidderivater. | |
AR024060A1 (es) | Nuevos compuestos farmaceuticamente activos | |
MX9305379A (es) | Nuevos derivados de aminoacidos, procedimiento para su preparacion y preparado farmaceutico que los contiene. | |
AR029210A1 (es) | DERIVADOS DE N-(5-SULFAMOIL-1,3-TIAZOL-2-IL) ACETAMIDA, PROCEDIMIENTO PARA SU PREPARACIoN, COMPUESTOS INTERMEDIARIOS, COMPOSICIoN FARMACÉUTICA, Y EL USO DE DICHOS DERIVADOS PARA LA PRODUCCIoN DE MEDICAMENTOS | |
AR033306A1 (es) | Compuestos | |
ES2075648T3 (es) | Composicion para frenar la caida de los cabellos, y para inducir y estimular su crecimiento, a base de derivados de pirimidinas-n-oxido trisustituidas en las posiciones 2, 4 y 6 por una funcion amina, y nuevos compuestos de pirimidina-n-oxido. | |
PE20030447A1 (es) | Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol-3-il)-sustituidos y su obtencion | |
ECSP23095485A (es) | N-(hidroxialquil (hetero)aril) tetrahidrofurano carboxamidas como moduladores de canales de sodio | |
ES2179353T3 (es) | Antagonistas muscarinicos. | |
DE3852085D1 (de) | Substituierte N-(1-Alkyl-3-hydroxy-4-piperidinyl)benzamide. | |
UY28317A1 (es) | Compuestos útiles para el tratamiento de enfermedades | |
PE20150638A1 (es) | Aminas ciclicas | |
ES2038172T3 (es) | Procedimiento para preparar carboxamidas heterociclicas. | |
MX9304467A (es) | Nuevos derivados fosfonados de ariletanolaminas, procedimiento para su preparacion y composiciones farmaceuticas y veterinarias que los contienen. | |
MX9400070A (es) | Compuestos heterociclicos, un procedimiento para prepararlos, su uso y composiciones farmaceuticas que los contienen. | |
MX9205123A (es) | Derivados de 5-hidroxi-2-pirimidinilmetileno utiles como agentes anti-inflamatorios. | |
ES2167021T3 (es) | Derivados de acido 4-bifenil-4-hidroxibutirico sustituidos como inhibidores de metaloproteasa de matriz. | |
PA8475401A1 (es) | Compuestos de sulfonilbenceno como agentes antiinflamatorios/analgesicos | |
ES514619A0 (es) | "procedimiento para la preparacion de derivados de arilamina". | |
CO5590934A2 (es) | Procedimiento de preparacion de derivados de equinocandina | |
AR008244A1 (es) | Compuestos heterociclicos, procedimiento para prepararlos, composiciones farmaceuticas que los comprenden, uso de dichos compuestos en la fabricacion de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos | |
AR043186A1 (es) | Indozolamidas dotadas de actividad analgesica, metodo de preparacion de las mismas y compuesto farmaceutico que las comprende |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 220066 Country of ref document: ES |